Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 Studies

被引：0
|
作者：
David Pariser
Ellen Frankel
Joel Schlessinger
Yves Poulin
Ronald Vender
Richard G. Langley
Xiangyi Meng
Adriana Guana
Judit Nyirady
机构：
[1] Eastern Virginia Medical School and Virginia Clinical Research,Department of Medicine
[2] Inc.,undefined
[3] Clinical Partners,undefined
[4] LLC,undefined
[5] Advanced Skin Research Center,undefined
[6] Laval University and Centre Dermatologique du Québec Métropolitain,undefined
[7] McMaster University,undefined
[8] and Dermatrials Research Inc.,undefined
[9] Dalhousie University,undefined
[10] Novartis Pharmaceuticals Corporation,undefined
来源：
Dermatology and Therapy | 2018年 / 8卷
关键词：
Clear or almost clear skin; Clinical trial; North America; Patient-reported outcomes; Pooled; Psoriasis; Quality of life; Secukinumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：17 / 32
页数：15
相关论文
共 50 条
  • [1] Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 Studies
    Pariser, David
    Frankel, Ellen
    Schlessinger, Joel
    Poulin, Yves
    Vender, Ronald
    Langley, Richard G.
    Meng, Xiangyi
    Guana, Adriana
    Nyirady, Judit
    [J]. DERMATOLOGY AND THERAPY, 2018, 8 (01) : 17 - 32
  • [2] Secukinumab was efficacious in the treatment of moderate to severe plaque psoriasis in the North American population: Pooled analysis of phase III studies
    Pariser, David
    Frankel, Ellen
    Schlessinger, Joel
    Meng, Xiangyi
    Guana, Adriana
    Nyirady, Judit
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB251 - AB251
  • [3] Efficacy of Secukinumab on Moderate-to-severe Plaque Psoriasis Affecting Different Body Regions: a Pooled Analysis of Four Phase 3 Studies
    Alan Menter
    Jennifer C. Cather
    Michael Jarratt
    Xiangyi Meng
    Adriana Guana
    Judit Nyirady
    [J]. Dermatology and Therapy, 2016, 6 : 639 - 647
  • [4] Efficacy of Secukinumab on Moderate-to-severe Plaque Psoriasis Affecting Different Body Regions: a Pooled Analysis of Four Phase 3 Studies
    Menter, Alan
    Cather, Jennifer C.
    Jarratt, Michael
    Meng, Xiangyi
    Guana, Adriana
    Nyirady, Judit
    [J]. DERMATOLOGY AND THERAPY, 2016, 6 (04) : 639 - 647
  • [5] Secukinumab is efficacious in the treatment of moderate to severe plaque psoriasis regardless of sex of subjects: Pooled analysis from four phase 3 studies
    Spelman, L.
    Griffiths, C.
    Gong, Y.
    Fox, T.
    Papavassilis, C.
    [J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2016, 57 : 74 - 75
  • [6] Secukinumab efficacy in subjects with moderate to severe plaque psoriasis: Pooled subgroup analyses by patient age of 4 phase 3 clinical studies
    Warren, Richard
    Guettner, Achim
    Morita, Akimichi
    Gisondi, Paolo
    Cooper, Simon
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) : AB186 - AB186
  • [7] Efficacy and Safety of Secukinumab in Elderly Subjects with Moderate to Severe Plaque Psoriasis: A Pooled Analysis of Phase III Studies
    Koerber, Andreas
    Papavassilis, Charis
    Bhosekar, Vaishali
    Reinhardt, Maximilian
    [J]. DRUGS & AGING, 2018, 35 (02) : 135 - 144
  • [8] Efficacy and Safety of Secukinumab in Elderly Subjects with Moderate to Severe Plaque Psoriasis: A Pooled Analysis of Phase III Studies
    Andreas Körber
    Charis Papavassilis
    Vaishali Bhosekar
    Maximilian Reinhardt
    [J]. Drugs & Aging, 2018, 35 : 135 - 144
  • [9] Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials
    Adsit, Sandra
    Rivas Zaldivar, Enrique
    Sofen, Howard
    Dei-Cas, Ignacio
    Maldonado-Garcia, Cesar
    Penaranda, Elkin O.
    Puig, Luis
    Meng, Xiangyi
    Fox, Todd
    Guana, Adriana
    [J]. ADVANCES IN THERAPY, 2017, 34 (06) : 1327 - 1339
  • [10] Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials
    Sandra Adsit
    Enrique Rivas Zaldivar
    Howard Sofen
    Ignacio Dei-Cas
    César Maldonado-García
    Elkin O. Peñaranda
    Luís Puig
    Xiangyi Meng
    Todd Fox
    Adriana Guana
    [J]. Advances in Therapy, 2017, 34 : 1327 - 1339
12345